Subject to change.
Subject to change.
Dr Hartman is leading the breast pathology program at Karolinska University Hospital and (full) professor of tumor pathology at Karolinska Institutet. Dr Hartman´s research focus is prognostic and drug-response prediction in breast cancer. The team works with genomics, machine learning and computational pathology. Dr Hartman has published > 150 scientific papers and > 12.000 citations. He is co-founder of the Karolinska spinn-out company Stratipath developing AI-models for precision pathology.